Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Other Current Assets

As of the most recent data (June 2026), BLACR shows a other current assets of $770K. That compares with $1.1M in the prior-year period — down 29.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACR's other current assets is now $770K (was $1.1M) — a 29.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is outperforming or lagging.

Tracking BLACR's other current assets over time shows whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is scaling, shrinking, or reshaping that part of the business. The current reading is $770K That compares with $1.1M in the prior-year period — down 29.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $770K) with ownership activity and broader fundamentals.